Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial

The aim of this study was to define the recommended dose of oxaliplatin when combined with infusional 5-fluorouracil (5-FU) and concurrent pelvic radiotherapy. Eligible patients had inoperable rectal cancer, or symptomatic primary rectal cancer with metastasis. Oxaliplatin was given on day 1 of week...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Loi, S, Ngan, S Y K, Hicks, R J, Mukesh, B, Mitchell, P, Michael, M, Zalcberg, J, Leong, T, Lim-Joon, D, Mackay, J, Rischin, D
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2005
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361867/
https://ncbi.nlm.nih.gov/pubmed/15700033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602413
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak